Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) Financials
Annual financial statement highlights for Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda covering fiscal years 2017–2025. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025ended Dec 2025 | 4.1B | 289.61M | 0.13 | -199.57M | 5.34B | 2.41B | 0.03 |
| 2024ended Dec 2024 | 2.77B | 381.84M | 0.18 | -371.85M | 4.31B | 1.57B | 0.08 |
| 2023ended Dec 2023 | 1.92B | 239.5M | 0.11 | -135.54M | 3.22B | 1.11B | 0.05 |
| 2022ended Dec 2022 | 1.48B | 240.48M | 0.12 | -5.03M | 2.77B | 930.18M | 0.00 |
| 2021ended Dec 2021 | 1.25B | 166.39M | 0.08 | 188.68M | 2.42B | 879.94M | 0.00 |
| 2020ended Dec 2020 | 960.17M | 97.48M | 0.05 | -249.31M | 2.25B | 929.56M | 0.00 |
| 2019ended Dec 2019 | 893.97M | 82.39M | 0.04 | -28.44M | 1.87B | 627.72M | 0.00 |
| 2018ended Dec 2018 | 805.21M | 129.02M | 0.08 | -213.99M | 1.22B | 588.13M | — |
| 2017ended Dec 2017 | 628.45M | 89.45M | 0.05 | -58.88M | 804.42M | 355.23M | — |
All figures in EGP, as reported in the company’s annual results; updated weekly.